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 SMOOTH: Self-Management Open Online Trials in Health  
Analysis Found Improvements Were Needed for Reporting Methods of Internet-
based Trials 
 
BACKGROUND 
The growth of trials conducted over the internet has increased, but with little practical guidance for their 
conduct and it is sometimes challenging for researchers to adapt the conventions used in face-to-face trials 
and maintain the validity of the work.  
AIM 
To systematically explore existing self-recruited online randomized trials of self-management interventions 
and analyze the trials to assess their strengths and weaknesses, the quality of reporting and the involvement 
of lay persons as collaborators in the research process. 
METHODS 
The Online Randomized Controlled Trials of Health Information Database (ORCHID) was used as the 
sampling frame to identify a subset of self-recruited online trials of self-management interventions. The 
authors cataloged what these online trials were assessing, appraised study quality, extracted information on 
how trials were run and assessed the potential for bias. We searched out how public and patient participation 
was integrated into online trial design and how this was reported. We recorded patterns of use for 
registration, reporting, settings, informed consent, public involvement, supplementary materials, and 
dissemination planning. 
RESULTS  
The sample included 41 online trials published from 2002-2015. The barriers to replicability and risk of bias  
in online trials included inadequate reporting of blinding in 28/41 (68%) studies; high attrition rates with 
incomplete or unreported data in 30/41 (73%) of trials; and 26/41 (63%) of studies were at high risk for 
selection bias as trial registrations were unreported. The methods for (23/41, 56%) trials contained 
insufficient information to replicate the trial, 19/41 did not report piloting the intervention. Only 2/41 studies 
were cross-platform compatible. Public involvement was most common for advisory roles (n=9, 22%), and 
in the design, usability testing and piloting of user materials (n=9, 22%) 
CONCLUSIONS  
This study catalogs the state of online trials of self-management in the early 21st century and provides 
insights for online trials development as early as the protocol planning stage. Reporting of trials was 
generally poor and, in addition to recommending that authors report their trials in accordance with 
CONSORT guidelines, we make recommendations for researchers writing protocols, reporting on and 
evaluating online trials. The research highlights considerable room for improvement in trial registration, 
reporting of methods, data management plans, and public and patient involvement in self-recruited online 
trials of self-management interventions.   
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Highlights 
Barriers to replicability, knowledge transfer and future progress in online trials were identified 
because of unclear reporting of various aspects of the trial design and the methods used. The 
deficits could be overcome by better reporting on the methods, dashboard design, data protection 
measures, software used for delivering the intervention and online materials used to train, test, and 
assess participants.  
 
The technology needed for the different devices that would be used to access the interventions 
tested in online trials may be too recent, costly to develop, or insufficiently stable for widespread 
use at the time of the trial. Therefore, better reporting of the trial methods may provide a way for 
research quality and innovation to keep pace with emergent technologies in the future. 
 
The sporadic use of different reporting guidelines in online trials at the moment prompts us to 
propose the development and implementation of a generic protocol for online trials that would 
contain embedded elements that are by relevant reporting guidelines to assist authors in writing up 
online trials, particularly those that use a participatory approach. 
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Background 
 
Modern digital technologies can provide health interventions through the use of mobile health apps, text 
messaging and telehealth video consulting, and provide an opportunity to conduct research solely over the 
internet in the format of online randomized trials. These trials can be conducted remotely over the internet 
using a computer, tablet, or smartphone without the need for face to face human interactions.  Online trials 
continue to grow in scope and accessibility, and patients are becoming empowered to use these technologies 
to explore their health questions. However, the methods used for these trials raise specific benefits and 
challenges.  
 
The aim of this research is to systematically explore existing self-recruited online randomized controlled 
trials of self-management interventions and analyze the trials to assess their strengths and weaknesses and to 
report how participants were involved in the research process  with the objective of  developing  guidance 
for the design, conduct and reporting of online RCTs of self-management interventions 
 
The benefits of using digital technologies for online trials include cost-reduction through the use of online 
rather than physical trial sites, ease of reaching multiple socio-demographic groups, the ability to use 
multiple languages with minimal cost and the inclusion of trial participants who have limited mobility but 
who can participate with access to an internet connection, through a computer, tablet, or smartphone (1). 
These trials can also provide insights into the use of interventions outside of the lab or clinic, and online 
access has become affordable and accessible in low resource settings providing more equitable global access 
to research. Public health and epidemiology researchers in low resource areas struggle with the challenge of 
accessing valid data on disease and population, where collection methods are inconsistent, culturally 
diverse, and subject to administrative delay(2). Mobile device platforms might be designed for collecting 
valid health research data from the potential 5 billion unique mobile subscribers who account for 67-80% of 
the world’s population as of May 2018 according to the GSMA intelligence calculator(3). 
 
Online trials have unique methodological challenges including limited face to face interaction, limited to 
participants who are willing to respond online, reliance on self-reported outcomes, and the need for 
applications to work across different operating systems, be user accessible and compatible with aging 
technology and bandwidth variations (4). Data protection breaches may be brought on by participants 
themselves through social media, or through health research data, purchased or stolen by third parties (5). 
Inconsistent reporting of methods and public and patient involvement in online trials can limit opportunities 
for research replication, end-user experience transfer, and the development of strategies to build on previous 
work (6). Therefore, research analyzing current practice for these trials might help in developing strategies 
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to improve recruitment, intervention adherence, participant retention, research methods, and reporting 
practices (7).  
 
Writing protocols to conduct online trials and to report them requires robust methods, informed by best 
practice. To learn from previously published research, the Online Randomized Controlled of Health 
Information Database (ORCHID) was constructed to collect reports of online trials and methodology 
research about them (8), using a search strategy available in appendix-1. ORCHID was used to investigate 
reporting methods, and the extent of public involvement in online trials and preliminary analysis showed 
that the number of online clinical trials was growing exponentially but with limited methodology research 
on validity and best practice of these trials (8).  
 
In this research study, we analyzed randomized self-recruited, self-management trials conducted over the 
internet. Self-recruitment is defined as the participants themselves enrolling in a trial online, via smartphone, 
tablet or computer without assistance by face to face contact with trial personnel. For this study, self-
management or self-monitoring of health is the use of a medical device, intervention or process that, while it 
may be recommended by a physician or other clinician, can be used or undertaken without the assistance of 
a healthcare professional. For example, self-help, wellness, diet, activity, therapy online, an anticoagulation 
medication that is monitored and titrated by the patient or asthma medications with peak flow measurement 
recorded by patients are eligible, but interventions that are fully clinician dependent for interpretation such 
as radiological films or lab work are not. This study investigates factors affecting the conduct of online trials 
of self-management and identifies if, and how, these trials report the involvement of patients and public in 
their design (9,10).  
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Methods 
Study Design  
A systematic review of the methods of online randomized trials of self-management interventions.  
 
Inclusion and Exclusion Criteria 
Inclusions 
Studies were included if they were randomized trials with online self-enrollment and used internet-based 
technologies, such as computers, tablets or smartphones, in the trial process. Interventions had to be related 
to health and well-being and could include educational or behavioral components; Trials were only included 
when there were self-reported outcomes. 
 
Exclusions 
Interventions in social care or education were excluded where outcomes were not health-related; where the 
population was exclusively health professionals, educators, or students; and the intervention was used for 
training purposes but was not a specific health intervention. Studies were excluded if clinicians or other 
health practitioners enrolled the population and physician intervention was needed to measure primary 
outcomes. Non-randomized trials, cost-effectiveness research, and studies that were reported only as 
conference presentations or posters were excluded, as were aborted or withdrawn trials. 
Data Sources and Search Strategy 
The Online Randomized Controlled Trials of Health Information Database (ORCHID) (8) (updated in July 
2016) was searched for identifying eligible trials. 
 
Screening and Selection of Reviews  
All citations were screened in RAYYAN which is an open-access tool for screening and appraising studies 
for systematic reviews (11). Reviewers were not blinded to author, institution, or journal. Two researchers 
independently screened the title and abstract of all citations retrieved from ORCHID for those that met the 
eligibility criteria. Citations were categorized as include, unsure (without checking of full paper), or exclude.  
Full papers were retrieved for those categorized as “include” or "unsure." Exclusions were not documented 
at this stage. Full papers were stored and de-duplicated in Mendeley (12). Two authors independently 
screened these full papers for eligibility and agreement was reached by consensus with a third author if they 
could not agree on inclusion or exclusion. Reasons for exclusion were documented. A PRISMA (13) flow 
diagram is included. 
 
Sampling Rationale  
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Studies were grouped into the following strata: feasibility or pilot studies and full trials, because scoping of 
the literature and consultation with experts in trials methodology showed that important choices about 
methodology and engagement might be detailed in feasibility or pilot trials but not included in the final trial 
report. Half the studies were then randomly selected from each stratum using a proportionate stratified 
sampling technique. 
 
Data Extraction  
Two authors independently extracted key data for the randomly selected included trials. The data extraction 
form was piloted in EPPI reviewer (14) and adapted for best use of resources and information quality. 
Results are presented using descriptive statistics and narratives. We report study characteristics and then 
cataloged what these online trials were assessing, assessed the methodological quality of the studies and the 
reporting methods used, and reported the potential for bias. We also sought information on how public and 
patient participation was integrated into the design of the online trial and how this was reported and noted 
the use of reporting guidelines, accessibility of supplementary materials, protocol registrations, and whether 
plans for dissemination were reported. 
 
Study Characteristics  
Details for each included study containing the citation, study design, aims, objectives, study setting, health 
status of participants, demographics, sample size calculation, intervention details, outcomes, time–points 
and follow-up were prepared and included along with a table of excluded studies with reasons for exclusion. 
Included trials were quality assessed for methodological strengths and weaknesses by two review authors. 
Discrepancies were resolved by consensus, without the need for third-party consultation. The Critical 
Appraisal Skills Programme (CASP) “11 questions to help you make sense of a trial checklist”(15) was 
used, and each item was scored as yes, no, not sure/not reported. The aggregated “yes” count was used as a 
guide to quality across studies.  
 
Assessment of Reporting  
We report the number of trials that included a systematic review to justify the trial’s testing of the 
intervention, a link to a registered protocol, included a CONSORT flow diagram (16), used CONSORT 
eHealth (17) reporting guidelines, used CONSORT PRO (18) to report patient-reported outcomes and 
contained an intention to treat analysis. For studies using an online questionnaire, we reported whether 
studies used the CHERRIES (19) reporting guideline.  
 
Assessment of Public and Patient Involvement 
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We report a summary of how, and at what stages, public and patient involvement occurred and whether the 
studies used GRIPP-2 (20) for reporting this involvement.  
 
Risk of Bias 
Two authors independently assessed the included studies using the Cochrane Risk of Bias tool categorizing 
risks as 'low,' 'high' or 'unclear.' Individual bias items were evaluated as described in the Cochrane 
Handbook for Systematic Reviews with modifications (21). Risk of reporting bias (selective reporting of 
results) did not use prospective trial registration as criteria as some trials were initiated before the 
expectation that trials be prospectively registered. Performance bias arising from self-reported outcomes was 
not assessed because the eligibility criteria included self-reported outcomes.    
 
Public and Patient Participation  
Members of the public collaborated as research partners during this study, from editing the protocol to 
designing, analyzing, contributing to the discussion and write up of the findings. A volunteer from Cochrane 
Task Exchange joined the research team (LV) and fulfilled the criteria accepted for authorship. The protocol 
was published in the public domain (22) and the link posted on social media (Twitter/Facebook/LinkedIn 
/Research Gate) for comments.  
 
Analysis   
Results are presented with descriptive statistics and narratives, using charts and tables for ease of 
understanding and visual comparisons. Characteristics of included studies are presented in Appendix-1 with 
the citation, study design, aims, objectives, study setting, the health status of participants, demographics, 
sample size calculation, intervention details, outcomes, time–points and follow-up. 
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Results 
Study identification 
Figure 1 shows the flow of studies through this review. 
 
Figure-1 PRISMA Flow diagram 
ORCHID contained 26,000 citations in July 2016. From these, 3636 de-duplicated citations were identified 
as randomized trials, and their titles and abstracts were screened for potential eligibility. Of these, 3543 
citations were excluded, leaving 91 articles for full-text screening. These reports were stratified into full 
trials (n=81) and pilot trials (n=10), and the subsequent 50% randomly selected samples included 41 full 
trials and five feasibility/pilot trials (total n=46).  
 
Studies Included for Full-Text Screening 
The full-text screening of the 46 articles for eligibility, led to the exclusion of 5: not self-enrolled in trial 
(n=2) (23,24), protocol (n=1) (25), secondary analysis (n=1) (26) and not self-reported outcomes plus quasi-
experimental design (n=1) (27). All 41 eligible trials were included for data extraction and analysis.  
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Characteristics of Studies 
Appendix 3 shows the characteristics of included trials (28–57) and excluded studies with reasons for 
exclusions (23–27). There were 29,348 randomized participants in the 41 include trials, and we included 
data for 19,357 in the analysis. Trials ranged in size from 48 to 9919 participants, with the length of 
intervention varying from 1 to 104 weeks.  All trial reports were available in English. Trials were hosted 
from nine countries with eight studies featuring multi-national collaborators (Table 1). Of the 41 trials, 30 
were published between 2011-2015, eight from 2006-2010 and three between 2002-2005.  
 
Trial Design  
All 41 trials were coded as pragmatic rather than explanatory because each contained self-reported data with 
self-management interventions. Pragmatic trials are used to measure the benefit that treatment produces in 
everyday life and reflect variations between patients that occur in everyday life, whereas  explanatory trials 
recruit homogeneous, carefully defined participants and conduct the research in a controlled setting.  Trial 
designs were parallel (n=32), factorial (n=1), waitlist controls (n=17), and pilot or feasibility studies (n=4). 
The participatory design was mentioned in 2 studies, but this PPI was restricted to consultation before trial 
preparation. Comparisons were assessed by waitlist controls (n=17), alternative interventions (n=19), current 
practice or standard of care (n=7), and dose-response (n=1). 
 
Trial Origins and Funding Sources 
Funding sources were reported in (34/41,83%) trials. Multiple funding sources were reported in 15 studies. 
Trials were funded by government (national funders and academic institutions) (n=25/41,59%), industry 
(n=3), NGOs (non-governmental organizations, trusts or charities (n=13, 32%). One trial was partially 
sponsored by advocacy groups who collaborated with the researchers on designing and running the trial. 
Information on funding was reported for 2 of the four feasibility/ pilot trials.  No trial sought crowd funding 
or was fully participant led and funded. All trials were initiated in high resource regions (Table-1).  
Table-1Trial host countries 
Country of origin for Trials Number of Trials 
USA 18 
Multi-national 8 
Sweden 5 
Netherlands 5 
Australia 4 
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UK 3 
Canada 2 
Japan 2 
Ireland 1 
Switzerland 1 
 
Recruitment  
The included studies reported a variety of methods and sources for recruitment including various online and 
offline methods:  use of websites, (n=5), healthcare centers (n=5), online-forums (n=4), bulletin-boards 
(n=4), Craigslist (n=4), other universities (n=4), advocacy organisations (n=4), communities (n=3), schools 
(n=3), social media (n=3), newsletters (n=3), internet advertising (n=3), worksites (n=2), newspapers (n=2) 
and conferences (n=1/41). Smartphone advertisements, texting, use of professional recruiters, canvassing at 
large advocacy organizations, recruiting through massive open online classrooms (MOOCs), online clinical 
sites, or referral arrangements from other trials were not reported as sources of recruitment.  
  
Intervention settings 
In online trials, “setting” includes the platform and materials used to conduct the intervention. Computers 
were the primary devices (n=38/41, 93%), followed by smartphones (n=4) and tablets (n=2). The studies 
using smartphones and tablets did not report usability across operating systems or devices. Only one study 
reported using wearable devices to passively collect health data which participants reported on and used to 
adapt their lifestyles. In 23 (56%) of studies, the description of the settings is insufficient to facilitate 
replication of the intervention and in 19/41, 46% studies piloting, or testing of platforms went unreported. 
Online or offline data entry was available in 7 trials, but most 24 (56%) specified that data could not be 
entered unless participants connected to the internet. The option to share or download personal data was 
reported in 4 (10%) of trials. Automated password recovery was supplied for nine trials. Only ten trials 
reported the inclusion of methods for explaining data entry to participants.  
 
Informed Consent  
Digital signatures for informed consent were accepted in 24 (56%) studies, 5 required only computer text 
(typing in yes/no or accept/decline), multimedia packages were used in 3 trials, and two trials used 
interactive formats for consent or participation information sheets. Trials did not report testing for 
participant comprehension or having end users as collaborators to develop patient information sheets and 
consents.  In 7 trials, the method for obtaining consent was unspecified. There were no reports of biometric, 
multi-trial consents (such as those used in adaptable trials) or the use of participant downloadable formats. 
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Intervention and Outcome Types 
We classified self-management interventions into the categories and outcomes in figure 2. All included trials 
measured behaviors. Trials could belong to multiple categories and contain more than one general outcome. 
Nine trials assessed knowledge in the general outcomes, while 29 trials (71%) assessed attitudes or 
behaviors.  
 
 
 
 
 
Figure 2 Interventional and general outcomes types  
Reminders and Incentives 
The majority of trials used email for reminders (n=28). Platforms enabled participants to set reminders in 2 
trials, and text reminders were implemented in one trial. Personalized, specific feedback was introduced as 
an incentive and later recommended by authors in 6 trials. Financial incentives ranging from US$25 to more 
than US$100 were offered over the course of the study in 17 trials (41%). Monetary incentives were 
available per task rather than as a lump sum in 10 trials. Using embedded methodology research, Bowen et 
al. (40), staggered the incentives per task and randomized half of the participants to higher payment for the 
last questionnaire. They found that increasing the incentive did not alter completion rates, which were 
similar for both groups.  
27
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Assessment of Methodological Quality 
We used the Critical Appraisal Skills Programme (CASP) 11 questions to help you make sense of a trial 
(15) to appraise quality across the trials. No trials received less than 2 yes responses, because having a 
focused question and randomization (items 1 and 2, respectively) were required by our inclusion criteria. 
The appraisal was based on the reporting within the trial’s publication without supplementation from 
personal correspondence with the original authors (table-2).  
 
Table- 2 CASP RCT Quality Appraisal Across Trials(15) 
 
CASP (How to Make Sense of a Trial) (15) 
 
Total of 41 
Trial Reports 
Questions 1-11 Yes No *? 
1. Clearly Focused Question? 41 0 0 
2. Randomized? 41 0 0 
3. Patients accounted for? 35 4 2 
4. Was blinding reported? 13 11 18 
5. Have groups similar demographics? 37 0 4 
6. Groups treated equally other than intervention? 37 2 2 
7. Treatment of effect size measured? 27 8 6 
8. **Estimate of treatment effect/confidence intervals? 20 12 9 
9. Do results apply to the local population? 22 1 18 
10. Were all clinically important outcomes considered? 20 6 15 
11. Are the benefits worth the harms and costs? 35 2 4 
 
*? It was not reported, or the reporting was unclear or incomplete. **Yes = with confidence intervals. No = 
reported narratively or without confidence intervals 
We also searched whether a relevant systematic review, meta-analysis or primary research  was cited or the 
absence of the same mentioned to justify conducting the trial and this information was reported in 33/41 
trials. 
 
Assessment of Quality of Reporting  
Protocol registrations were reported in 15 trials. The CONSORT flow diagram was used in 18 trials with 
two including an intention to treat analysis. Piloting of the trial or platform was reported by 19 trials. 
Although the 41 trials included studies contained patient-reported outcomes and 40 trials contained an 
online questionnaire, none used the CHERRIES (19) reporting guideline for online surveys or CONSORT 
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Pro (18) for reporting patient-reported outcomes. Four papers used the CONSORT E-HEALTH (17) 
reporting guidelines. However, several of the trial reports preceded the publication of reporting guidelines, 
including the 2010 update of the main CONSORT statement (58).  
 
Assessment of Reporting Public and Patient Involvement (PPI) 
PPI (defined as involvement in the research other than as a trial participant) was reported in 10 trials and 
forms the participatory element in online trials. Face to face PPI and email were the most common forms of 
interaction with PPI. There was participation in steering groups, community sessions, board meetings, focus 
groups, pilot testing sessions, computer iteration labs, dashboard design, surveys, or interview design. In 
some trials, advocacy groups were used as a proxy for individual patients or the public. Four reports 
included PPI activity in the acknowledgments section. Trials implemented PPI for advisor roles (n=9), 
design of a trial interface and user materials (n=9), usability testing and piloting (n=9), recruitment (n=3), 
selection of outcomes (n=2), setting the research question (n=1) and translation (n=1). The ten trials 
reporting PPI did not cite the GRIPP-1(59) or GRIPP-2(20) guidelines for reporting, but, again, some of the 
trials pre-dated the publication of those guidelines. 
 
Risk of Bias  
The risk of bias from the generation of the random sequence was generally low because most studies used 
computer generated algorithms for randomization. Attrition (incomplete outcome data) and blinding of 
outcome assessment might be problematic for online trials as only 11 trials for each of these two domains 
showed a low risk of bias. For the blinding of participants or personnel, 12 trials were assessed as low risk 
of bias. Selective reporting is an important issue that is reduced when trial protocols are registered in 
advance. Trials that were not prospectively registered were assessed as unclear,  and trials were assessed as 
high when there was a discrepancy between the results of the paper and what was highlighted in conclusion 
and abstract or multiple areas of risk of bias including the absence of a trials registration or protocol. As 
already noted, analysis by intention to treat was reported in only two trials. One trial reported the number of 
participants in control and experimental groups but only reported the experimental condition. This trial had 
other areas that were high risk and so it was classified as high risk of bias not otherwise classified (other 
bias)*.  The prevalence of reporting bias in online trials was at least as high as in conventional trials (60). 
(Figure-3) 
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Figure 3  Risk of Bias across trials 
 
Discussion 
Summary of Results 
Quality was consistent or comparable to that of traditional trials. However, gaps central to the success of 
online trials were identified and recommendations to bridge these gaps were suggested in table-3. The 
barriers to replicability and risk of bias  in participatory online trials included inadequate reporting of 
blinding in 28/41 (68%) studies; high attrition rates with incomplete or unreported data in 30/41 (73%) of 
trials; and 26/41 (63%) of studies were at high risk for selection bias as trial registrations were unreported. 
Compliance and intervention engagement per session and over time were not systematically reported in the 
41 trials in our sample but could be seen in part by viewing the CONSORT flow diagrams, where higher 
adherence was common in waitlist control groups. This suggests the engagement with interventions over 
time were not optimal.  In 38/41 (93%) of studies computers were the only resource available for entering 
study data, and this is in contrast to the growing number of individuals, particularly in low resource settings 
who have smartphones or tablets as their primary vehicle for online usage. PPI was not referenced or 
reported in 31/41 (76%) of trials. In general, the methods were not reported with sufficient detail for 
replicating the work. A multi-use protocol template might help authors focus on trial methods, design. and 
implementation. .  
 
Comparison with Other Studies  
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To the best of our knowledge, this is the first review of the quality of a sample of online self-management 
trials, but similar reviews exist for more conventional trials. This study and those earlier studies show that 
these online trials face some of the challenges of face-to-face trials regarding validity, data security, viable 
methods and the challenge of providing valid self-reported outcomes (61). These may be greater challenges 
for online trials because of the lack of face-to-face interaction to troubleshoot participant interaction or 
assess validity. About PPI, our findings are similar to those reported by others (62,63). However, given the 
speed of the development of the internet and of devices that interface with it, the 41 trials in our sample 
might not reflect the current situation for online trials because of advances in methods and technology since 
the cut-off date for articles in ORCHID. 
Implications  
Challenges for Online Participatory Trials  
Our application of the CASP appraisal criteria identified only 1 of the 41 trials as low quality. The higher 
risk of bias scores may be due to features that online trial researchers are powerless to change, such as the 
use of self-reported outcomes. However, as with conventional trials, we found substantial barriers to 
replicability and progress due to the lack of clear reporting, for example about the setting where participants 
engaged with the intervention. Within online trials, settings can be particularly influential when one 
considers attrition in online trials that might arise due to unresolved technical difficulties. Designing, 
piloting and monitoring all interfaces with end-users could increase the durability, stability, and usability of 
the resources needed to complete the intervention and the trial, from enrolment of participants to follow-up. 
PPI collaborators in this study highlighted the importance of automated password recovery, plus online and 
offline data entry across devices. They identified a preference to access, manage, and share their research 
related data but also raised concerns about how research data might be shared for a fee with third parties 
without their specific consent. It would be useful for researchers doing online trials to consider these 
concerns. Behavioral interventions and waitlist controls featured in 17 trials. The use of a comparative 
intervention in a parallel design may produce more reliable results because the use of a waitlist control 
design might artificially inflate intervention effect estimates (64). The mechanism for this inflation may be 
the participant's determination to comply, so they will not miss out on the "real" intervention (65).  
 
Reporting challenges 
Inadequate reporting may not reflect a poor quality trial (66) but incomplete reporting and research without 
public input into the design can impede replicability and might lead to the unnecessary repetition of 
research, waste of resources, and unnecessary complexity (67,68). Reporting shortfalls may slow the 
redesign or implementation of existing interventions (69) and are not limited to online trials. Initiatives such 
as the “All Trials” campaign for registering all trials and reporting all results may help to redress some of 
these problems about the access to trial findings (70), and uptake of the TIDieR guidance should improve 
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the reporting of trial interventions(71). An additional limitation is that technology across devices may be too 
recent, costly to develop, or insufficiently stable for widespread adoption. The trial sample was published 
from 2002-15, and some studies in the sample were designed several years before this, in a time when 
computers (rather than mobile phones or tablets) were the primary interface for the internet.  
 
Supplementary materials  
Supplementary materials were not always accessible for the trial reports. This is a particular problem if the 
article is downloaded for offline use. Details of the software used in online trials were reported using static 
screenshots leaving insufficient information on models, coding structure, or usability for replication. We 
recognize that the sample of trial reports was published from 2002-2015 and earlier papers may have been 
written for print journals without an option to store supplementary files, models or software. Furthermore, 
even current online journals may be restricted by the file structures their platforms can process. However, 
researchers might be able to comply with the FAIR standards (findable, accessible, interoperable, re-usable) 
by using responsive multi-file open access repositories such as Zenodo, Dataverse, or GitHub and putting 
links to the files in their publication (72).  
 
Dissemination  
If the main report of a trial is not published open access, free-to-view dissemination of its findings can still 
take place through, blogs, social media, and teaching. It is also increasingly possible for researchers to 
provide free access to pre-publication versions of their manuscripts through institutional repositories. 
Dissemination strategies are not adequately addressed within existing reporting guidelines or protocol 
templates, leaving researchers with insufficient guidance on how to report or highlight their dissemination 
strategies (other than, perhaps, within the relevant sections of their applications for funding).  
 
Study Limitations 
Identifying relevant online trials presented a challenge given the lack of specific search terms that are 
available in bibliographic databases such as MEDLINE and Embase. To help mitigate this, the design of 
ORCHID (from which we searched the included trials) was underpinned by research on search strategies 
and filters to establish the optimal trade-off between exhaustiveness and precision; and, so, we believe that 
we have a representative sample of eligible trials from the early 21st century. We limited the analysis to fifty 
percent of the 81 titles and abstracts that matched inclusion criteria as the research was unfunded. We note 
that quality improvement assessments traditionally analyse only a 10% sample of the available data.  As 
with other assessments of trial quality (65), our analysis was dependent on what authors reported, which 
may differ from what they did. We assessed the trials who did not report protocol publication or trials 
registration as unclear for risk of selective reporting.  For trials enrolling participants before 2005 this may 
reflect changes in reporting requirements rather than the trial quality.  Clinicaltrials.gov originally 
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encouraged registration for trials that dealt with serious illness. This position was expanded when The 
International Committee of Medical Journal Editors (ICMJE) announced in 2005 that their journals would 
no longer publish reports of trials unless they were prospectively registered in a trial registry that met the 
quality standards recommended by the World Health Organization (73). The risk of  selective reporting 
remains a threat in  2017 where approximately one third of trials listed in ClinicalTrials.gov were registered 
three months following participant enrollment and of these, fifty percent were not registered within the first 
12 months (74).  In addition, not all trials report the outcomes that are consistent with registry entries(75). In 
online trials, limited guidance available to support online trial protocols or registration is cited (8) and it is 
hoped that bridging the reporting gap might reduce the risk of bias in online trials. We were unable to access 
additional potentially relevant information stored in inaccessible formats, contained in related, but unlinked 
papers, or that was unreported. However, our analyses reflect the information that is readily accessible to 
users of these trials and, therefore, is valid as a description of what can be easily found by users of online 
trials.  
 
Future Directions and Conclusions  
The SMOOTH (Self-Management of Open Online Trials in Health) analysis highlights the importance of 
consideration being given to good practice and reporting as early as the protocol planning stage for an online 
trial. Reporting of trials was generally poor. In addition to recommending that authors report their trials in 
accordance with CONSORT guidelines, we make the following recommendations Trialists should cover 
when reporting, and readers of trials should evaluate when reading, an online participatory clinical trial 
(some of these may also be applicable to non-online trials): There are items included in a protocol that will 
not be reported in the final manuscript. These might be described as aspirational, whereas the manuscript 
reports what took place. For example, a protocol could have a back-up plan for recruitment when the sample 
size is not reached or for alternative equipment if technology fails, however, this is unlikely to be reported in 
the published manuscript. Also, there may be handbooks, software algorithms, and models that will not be 
part of a short protocol document, but they are trial documentation that is needed to replicate the work. This 
is why links to protocol registrations and other relevant trial documentation need to be reported in the 
published report.  
 
Table 3 Protocol and reporting recommendations to evaluate for online participatory trials 
Checklist Item   Research Recommendation for Online Participatory Trials 
Trial title and 
registration 
The trial registration is reported, prospective, and has IRB approval. Include in the 
title the fact that the trial was online 
Study Design  State design, describe arms, report number of participants in each arm, report if 
control group will have access to the intervention post-trial, report online components 
if the trial is not fully online.   
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Checklist Item   Research Recommendation for Online Participatory Trials 
Public and 
patient research 
involvement(PPI)  
Report at what stages and in what form members of the public were involved in the 
research as part of the research team. Report in what ways they contributed to the 
design, oversight, running, analysis, and writing up of the trial report. 
We suggest PPI be reported in the methods section with a link to other sources if 
applicable where PPI was reported. For a checklist of what to include and report in an 
online participatory trial, we suggest the GRIPP-2(20) short form reporting guidelines. 
Questionnaire 
Inclusion 
40/41 of the studies analyzed contained a questionnaire or survey. We recommend 
using and citing the Checklist for Reporting Results of Internet E-Surveys 
(CHERRIES)(19) for best research practice. 
Randomization The point at which randomization takes place, e.g., before or after collection of 
baseline characteristics (we recommend that it should be after collection of baseline 
characteristics to minimize attrition rates), 
Flow diagram Consider including a flow diagram to show the path of the participant through the 
intervention.  
Recruitment  Report methods used for recruiting and for validating that the data has come from a 
participant. 
Pilot or 
Feasibility 
State how the study was piloted. We recommend piloting with people not only using 
computer models or people familiar with the platform. Pilots need to be completed by 
fully online participants representative of the population in addition to any other 
platform testing that takes place. 
Informed consent Describe online informed consent methods, their validation and how participants 
could contact study personnel given the lack of face to face communication. 
 
Convey to participants the time resources and risks of contributing. Assess participant 
understanding and their knowledge of the purpose of the study. 
Setting  Describe in detail the software and algorithms used in the trial and the launch date of 
the online site. 
Include the period for which the online site remained open for recruitment, and in 
what timeframe the online site remained open for data input. 
Patient Reported 
Outcomes  
We suggest reporting how the outcomes were informed by patients and if patient or 
public volunteer assessments of the outcomes were carried out before launch. 
Specify parties, including patient contributors, who developed PRO content. 
For other areas of reporting patient outcomes, we recommend adopting the SPIRIT 
PRO extension(76).  
Replication Include access to all materials and settings needed to replicate the research. 
Include explicit statements about platform downtime or failures even if none occurred, 
as this may explain some loss to follow-up and the stability of the setting 
Compliance and 
loss to follow-up 
We recommend building on and reporting consistency and completeness checks at 
each stage of the intervention process as this contributes to best practice and 
replicability. 
Data protection  Outline how personal information was collected and protected. Include methods for 
password storage and recovery if applicable. 
 
Data Sharing Policy on retention and use of already collected data, if a participant withdraws from 
the intervention or control (we recommend that data collection should be used to 
optimize the information available to the study and that participants should be aware 
of this in informed consent) 
State who has access to the data during and post-trial including third parties and how 
this was consented. State whether participants will have the option to download 
personal data collected during the trial 
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Checklist Item   Research Recommendation for Online Participatory Trials 
Contributory 
statement 
Online trials may be run across countries and cultures with not all team members 
having access to the raw data. Stating who contributed and to what extent increases 
transparency and accountability 
Competing 
interests 
We recommend financial and personal competing interests be declared by all parties 
within the research team including members of the public or advocacy groups. 
Supplementary 
Materials 
If not supplied by the publisher, we suggest authors establish ways that the 
supplementary materials can be linked to the primary paper and in a file format that is 
accessible to readers. Multi-file type open access repositories can be used such as 
Zenodo, Dataverse, or GitHub(72). 
Dissemination Consider building and reporting on a dissemination plan for reaching non-
professionals. This could be through social media, blogs, the trial website, through the 
public report to the funders, and in conferences and training venues. 
 
The SMOOTH (Self-Management of Open Online Trials in Health) analysis reported here highlights the 
importance of consideration being given to good practice and reporting as early as the protocol planning 
stage for an online trial. Although online trials are still an emergent field, careful application of new findings 
for best research practice could improve the quality of online trials. The researchers' insights into ways to 
improve interventions or trial design were rarely discussed in publications even when authors trialed 
interventions repeatedly across conditions and populations with minimal difference in effect (77,78). Online 
trials could benefit from the practicality and cost savings of applying methodology research within the 
context of a functioning trial, nesting Studies Within A Trial (SWAT) (79) in host trials and by making use 
of the Trial Forge initiative (80). Following the sporadic use of reporting guideline in these reports of online 
trials, we propose the development and implementation of a reusable online protocol that follows good 
practice for reporting these trials. An adaptable protocol template could provide strategies for data 
management plans, reusable interactive consent, patient and public involvement methods and a checklist to 
verify what to report from available guidelines when conducting an online trial. We also suggest that 
researchers might improve the uptake of their interventions by partnering with patients to improve access, 
usability, quality, and dissemination.  
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